British doctors who spent 102 days treating a cancer survivor for COVID-19 documented how the virus mutated after the man was treated with convalescent plasma. The case study suggests the use of blood plasma donated from COVID-19 survivors may have put enough pressure on the virus to force it to evolve. The result: Less susceptibility to immune system antibodies that normally fight off infection, according to the report published Friday in the journal Nature. While the convalescent plasma didn't seem to harm the patient, it offered no clear benefit, said senior author Ravindra Gupta, a professor of clinical microbiology at the Cambridge Institute of Therapeutic Immunology and Infectious Dis
Hence then, the article about chronic covid 19 and convalescent plasma may boost mutation risk was published today ( ) and is available onGulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Chronic COVID-19 and convalescent plasma may boost mutation risk )